Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
68.94 USD | -1.10% |
|
+6.17% | +121.70% |
Jun. 21 | Evercore ISI Boosts Price Target on Insmed to $75 From $42, Maintains Outperform Rating | MT |
Jun. 20 | JPMorgan Raises Insmed's Price Target to $72 From $55, Maintains Overweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.70% | 11.24B | |
+16.28% | 122B | |
+21.48% | 116B | |
+22.18% | 27.03B | |
-21.53% | 20.36B | |
-16.89% | 16.43B | |
-18.08% | 15.91B | |
-44.74% | 15.6B | |
+61.60% | 14.94B | |
+3.20% | 13.59B |
- Stock Market
- Equities
- INSM Stock
- News Insmed Incorporated
- UBS Raises Price Target on Insmed to $78 From $58, Maintains Buy Rating